Downregulation of Bcl-2 sensitises interferon-resistant renal cancer cells to Fas

Interferon α (IFNα) is used to treat patients with advanced renal cell carcinoma (RCC) despite limited clinical benefit. IFNα can induce Fas receptor-mediated apoptosis by direct activation of pro-caspase-8 followed by activation of caspase-3. Alternative, indirect activation of caspase-3 via mitoch...

Descripción completa

Detalles Bibliográficos
Autores principales: Kelly, J D, Dai, J, Eschwege, P, Goldberg, J S, Duggan, B P, Williamson, K E, Bander, N H, Nanus, D M
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2004
Materias:
Experimental Therapeutics
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364752/
https://www.ncbi.nlm.nih.gov/pubmed/15188008
http://dx.doi.org/10.1038/sj.bjc.6601895

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2364752/
https://www.ncbi.nlm.nih.gov/pubmed/15188008
http://dx.doi.org/10.1038/sj.bjc.6601895

Ejemplares similares